AnaptysBio, Inc. Common Stock Share Price
NASDAQ: ANABHealthcare
Live AnaptysBio, Inc. Common Stock Share Price Chart
O H L
AnaptysBio, Inc. Common Stock Performance Overview
Days Range
▼
$55.60Low
$55.77High
Markets Today
| Previous Close | $55.06 |
|---|---|
| Open | $55.60 |
| Volume | 32,511 |
| Day's Range | $55.60 - $55.77 |
| 52W Range | $12.98 - $72.36 |
| Market Cap | $1.61 B |
Historical Performance
| 1M Returns | -6.66 |
|---|---|
| 3M Returns | -4.26 |
| 6M Returns | -14.93 |
| 1Y Returns | +161.20 |
| 5Y Returns | +104.53 |
| 10Y Returns | NA |
AnaptysBio, Inc. Common Stock Fundamentals
| Market Cap | $1.61 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $234.60 M |
| ROE TTM | -0.24 |
| EPS TTM | $-0.88 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 123.69 |
| EBITDA | $48.45 M |
| Profit Margin | -5.64 |
| Market Cap | $1.61 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $234.60 M |
| ROE TTM | -0.24 |
| EPS TTM | $-0.88 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 123.69 |
| EBITDA | $48.45 M |
| Profit Margin | -5.64 |
AnaptysBio, Inc. Common Stock Profit & Loss
Quarterly
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $43.11 M | $27.77 M | $22.26 M | $76.32 M | $108.25 M | $25.56 M |
| Gross Profit + | $43.11 M | $27.77 M | $22.26 M | $76.32 M | $108.25 M | $25.56 M |
| Operating Income | -$9.67 M | -$27.54 M | -$26.17 M | $34.70 M | $66.90 M | -$34.64 M |
| EBITDA | -$9.53 M | -$27.39 M | -$26.03 M | $34.84 M | $67.03 M | -$34.51 M |
| Interest Expense | -$17.40 M | -$18.06 M | -$19.61 M | -$22.52 M | -$19.71 M | -$20.86 M |
| Depreciation | $145.00 K | $146.00 K | $142.00 K | $140.00 K | $131.00 K | $130.00 K |
| Income Before Tax | -$21.79 M | -$39.28 M | -$38.59 M | $15.11 M | $49.70 M | -$52.84 M |
| Income Tax Expense | -$6.00 K | $44.00 K | $39.00 K | $0 | $81.00 K | $40.00 K |
| Net Income + | -$21.78 M | -$39.33 M | -$38.63 M | $15.11 M | $49.61 M | -$52.88 M |
| Net Profit Margin | -50.53% | -141.62% | -173.52% | 19.8% | 45.83% | -206.93% |
AnaptysBio, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $30.00 K | $30.00 K | $28.00 K | $28.00 K | $28.00 K | $29.00 K |
| Reserve & Surplus | -$759.02 M | -$798.50 M | -$837.29 M | -$822.13 M | -$772.58 M | -$825.59 M |
| Non-Current Liabilities | $367.54 M | $344.00 M | $344.46 M | $344.41 M | $288.56 M | $275.24 M |
| Current Liabilities | $45.43 M | $44.04 M | $35.53 M | $38.10 M | $38.63 M | $41.70 M |
| Total Liabilities | $412.97 M | $388.03 M | $379.98 M | $382.51 M | $327.19 M | $316.94 M |
| Fixed Assets | $1.85 M | $1.74 M | $1.63 M | $1.50 M | $1.37 M | $1.28 M |
| Current Assets | $431.88 M | $363.11 M | $291.91 M | $330.65 M | $350.25 M | $316.11 M |
| Total Assets | $483.83 M | $422.05 M | $335.25 M | $353.10 M | $364.39 M | $329.68 M |
AnaptysBio, Inc. Common Stock Cash Flow
Quarterly
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$21.78 M | -$39.33 M | -$38.63 M | $15.11 M | $49.61 M | -$52.88 M |
| Operating Cash Flow | -$66.67 M | -$10.70 M | -$40.24 M | -$27.36 M | $98.00 M | -$25.92 M |
| Investing Cash Flow | -$29.40 M | $14.85 M | $36.40 M | $103.28 M | $73.50 M | $34.98 M |
| Financing Cash Flow | $27.57 M | -$28.59 M | -$50.50 M | -$10.39 M | -$43.13 M | $1.21 M |
| Change in Cash | -$68.50 M | -$24.44 M | -$54.34 M | $65.53 M | $128.36 M | $10.27 M |
AnaptysBio, Inc. Common Stock Return Calculator
The AnaptysBio, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$19,974
Invested Amount$10,000
Est. Returns$9,974
About AnaptysBio, Inc. Common Stock
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
Popular Stocks
FAQs
What is the share price of AnaptysBio, Inc. Common Stock today?
AnaptysBio, Inc. Common Stock (ANAB) share price as of September 18, 2026 is $53.77. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of AnaptysBio, Inc. Common Stock?
Yes, Indian Investors can invest in the AnaptysBio, Inc. Common Stock (ANAB) Share by opening an international trading account with Angel One.
How can I purchase AnaptysBio, Inc. Common Stock shares in India?
Purchasing AnaptysBio, Inc. Common Stock (ANAB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying AnaptysBio, Inc. Common Stock (ANAB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of AnaptysBio, Inc. Common Stock?
Yes, you can purchase fractional shares of AnaptysBio, Inc. Common Stock (ANAB) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of AnaptysBio, Inc. Common Stock?
The market capitalization of AnaptysBio, Inc. Common Stock on September 18, 2026, is $1.61 B.
In which sector AnaptysBio, Inc. Common Stock belongs?
AnaptysBio, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in AnaptysBio, Inc. Common Stock stocks?
In order to invest in AnaptysBio, Inc. Common Stock (ANAB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
